Neoadjuvant Cisplatinum Based Combination Chemotherapy in Patients with Invasive Bladder Cancer: A Combined Analysis of Two Nordic Studies
- 31 March 2004
- journal article
- Published by Elsevier BV in European Urology
- Vol. 45 (3), 297-303
- https://doi.org/10.1016/j.eururo.2003.09.019
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- A predictive model of survival after radical cystectomy for carcinoma of the bladderBJU International, 2008
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerThe New England Journal of Medicine, 2003
- Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysisThe Lancet, 2003
- Neoadjuvant Chemotherapy with Cisplatin and Methotrexate in Patients with Muscle-Invasive Bladder TumoursActa Oncologica, 2002
- Neoadjuvant Cisplatin-Methotrexate Chemotherapy for Invasive Bladder Cancer - Nordic Cystectomy Trial 2Scandinavian Journal of Urology and Nephrology, 2002
- Neo-adjuvant chemotherapy in invasive bladder cancer.World Journal of Urology, 2001
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Five-year Followup of a Prospective Trial of Radical Cystectomy and Neoadjuvant Chemotherapy: Nordic Cystectomy Trial 1Journal of Urology, 1996
- Original Articles: Bladder Cancer: Neoadjuvant Cisplatin Chemotherapy Before Radical Cystectomy in Invasive Transitional Cell Carcinoma of the Bladder: A Prospective Randomized Phase III StudyJournal of Urology, 1995
- Cis‐diamminedichloroplatinum (DDP) as Initial Treatment of lnvasive Bladder CancerBJU International, 1984